KALYDECO (ivacaftor)
CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH RESPONSIVE CFTR MUTATION
VERTEX PHARMACEUTICAL
Indication
Cystic fibrosis with responsive CFTR mutation
Cystic fibrosis with a responsive CFTR mutation is a genetically defined subset of cystic fibrosis, a progressive autosomal recessive disorder affecting multiple organ systems, most notably the respiratory and gastrointestinal tracts. Read more about Cystic fibrosis with responsive CFTR mutation
4 drugs 1 manufacturers
Drugs that treat it
Common Cystic fibrosis with responsive CFTR mutation therapies.
SYMDEKO (tezacaftor/ivacaftor)
CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE·+1
VERTEX PHARMACEUTICAL
TRIKAFTA (elexacaftor/tezacaftor/ivacaftor)
CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE·+1
VERTEX PHARMACEUTICAL
ALYFTREK (vanzacaftor calcium/tezacaftor/deutivacaftor)
CYSTIC FIBROSIS TRANSMEMB. CONDUCT. REG. (CFTR) POTENTIATORS·CYSTIC FIBROSIS WITH HOMOZYGOUS F508DEL MUTATION IN CFTR GENE·+2
VERTEX PHARMACEUTICAL
Filter & compare in the drug finder →Opens the drug finder with Cystic fibrosis with responsive CFTR mutation preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCystic fibrosis with a responsive CFTR mutation is a genetically defined subset of cystic fibrosis, a progressive autosomal recessive disorder affecting multiple organ systems, most notably the respiratory and gastrointestinal tracts.
The condition is caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator gene that yield a protein defect—such as impaired processing, gating, or conductance—capable of functional restoration when targeted by small-molecule modulators.
Pathophysiologically, defective CFTR channel activity impairs epithelial chloride and bicarbonate transport, dehydrating mucosal surfaces and generating thick, viscous secretions.
Clinically, affected patients experience chronic airway obstruction, recurrent bronchopulmonary infections, progressive bronchiectasis, and exocrine pancreatic insufficiency, but their specific genotype retains the molecular potential for pharmacologic enhancement of CFTR protein synthesis, trafficking, or open-channel probability.
- cfri.org
Cystic fibrosis with a responsive CFTR mutation is a genetically defined subset of cystic fibrosis, a progressive autosomal recessive disorder affecting multiple organ systems, most notably the respiratory and gastrointestinal tracts Pathophysiologically, defective CFTR channel activity impairs epithelial chloride and bicarbonate transport, dehydrating mucosal surfaces and generating thick, viscous secretions Clinically, affected patients experience chronic airway obstruction, recurrent bronchop...
- fda.gov
The condition is caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator gene that yield a protein defect—such as impaired processing, gating, or conductance—capable of functional restoration when targeted by small-molecule modulators Clinically, affected patients experience chronic airway obstruction, recurrent bronchopulmonary infections, progressive bronchiectasis, and exocrine pancreatic insufficiency, but their specific genotype retains the molecular potenti...
- cff.org
The condition is caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator gene that yield a protein defect—such as impaired processing, gating, or conductance—capable of functional restoration when targeted by small-molecule modulators Clinically, affected patients experience chronic airway obstruction, recurrent bronchopulmonary infections, progressive bronchiectasis, and exocrine pancreatic insufficiency, but their specific genotype retains the molecular potenti...
- medlineplus.gov
Pathophysiologically, defective CFTR channel activity impairs epithelial chloride and bicarbonate transport, dehydrating mucosal surfaces and generating thick, viscous secretions
Personalize your experience
Follow Cystic fibrosis with responsive CFTR mutation and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.